| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 147, 1693-1707, Copyright © 1995 by American Society for Investigative Pathology
REGULAR ARTICLES |
BD Car, VM Eng, B Schnyder, M LeHir, AN Shakhov, G Woerly, S Huang, M Aguet, TD Anderson and B Ryffel
Institute for Toxicology, University of Zurich, Schwerzenbach, Switzerland.
Interleukin 12 (IL-12) activates natural killer (NK) and T cells with the secondary synthesis and release of interferon-gamma (IFN-gamma) and other cytokines. IL-12-induced organ alterations are reported for mice and the pathogenetic role of IFN-gamma is investigated by the use of mice deficient in the IFN-gamma receptor (IFN-gamma R-/-). IL-12 caused a rapid infiltration of liver and splenic red pulp with activated macrophages; this and increased NK cells resulted in a fivefold increase of splenic weight in wild-type mice. Splenomegaly was associated with myelosuppression and decreasing peripheral leukocyte counts. IL-12-induced changes in wild-type mice were associated with markedly increased IFN-gamma serum levels and up-regulation of major histocompatibility complex (MHC) class I and II expression in various epithelia. IL-12 induced a qualitatively similar macrophage infiltration in IFN-gamma R-/- mice, less marked splenomegaly (to 2 x normal), and no MHC upregulation. Strikingly increased vascular endothelial intercellular adhesion molecule-1 expression was apparent in both IFN-gamma R-/- and IFN-gamma R+/+ mice. Restricted to mutant mice was a severe, invariably lethal, interstitial, and perivascular pulmonary macrophage infiltration with diffuse pulmonary edema. Extensive quantitative reverse transcriptase polymerase chain reaction analysis revealed an increase of only IL-6 and IL-10 pulmonary gene transcripts in IFN-gamma R-/- mice compared with wild-type mice. IL-12- induced myelosuppression is due to IFN-gamma-release from NK cells and T cells, and is associated with macrophage activation and distinct MHC class I and II antigen upregulation. The pulmonary pathology in IFN- gamma R-/- mice, however, reveals a toxic potential for IL-12 and suggests that endogenous IFN-gamma plays a protective role in preventing fatal pulmonary disease in these mice.
This article has been cited by other articles:
 |
|
 |
|
  C. M. Salvatore, M. Fonseca-Aten, K. Katz-Gaynor, A. M. Gomez, and R. D. Hardy Intranasal Interleukin-12 Therapy Inhibits Mycoplasma pneumoniae Clearance and Sustains Airway Obstruction in Murine Pneumonia Infect. Immun., February 1, 2008; 76(2): 732 - 738. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Siddiqui, C.-Y. Li, S. M. LaRue, J. M. Poulson, P. R. Avery, A. F. Pruitt, X. Zhang, R. L. Ullrich, D. E. Thrall, M. W. Dewhirst, et al. A phase I trial of hyperthermia-induced interleukin-12 gene therapy in spontaneously arising feline soft tissue sarcomas Mol. Cancer Ther., January 1, 2007; 6(1): 380 - 389. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Oniki, H. Nagai, T. Horikawa, J. Furukawa, M. L. Belladonna, T. Yoshimoto, I. Hara, and C. Nishigori Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanoma. Cancer Res., June 15, 2006; 66(12): 6395 - 6404. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. W. Chong, D. Metcalf, E. Jamieson, W. S. Alexander, and T. W. H. Kay Suppressor of cytokine signaling-1 in T cells and macrophages is critical for preventing lethal inflammation Blood, September 1, 2005; 106(5): 1668 - 1675. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Nolt and J. L. Flynn Interleukin-12 Therapy Reduces the Number of Immune Cells and Pathology in Lungs of Mice Infected with Mycobacterium tuberculosis Infect. Immun., May 1, 2004; 72(5): 2976 - 2988. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Hisada, S. Kamiya, K. Fujita, M. L. Belladonna, T. Aoki, Y. Koyanagi, J. Mizuguchi, and T. Yoshimoto Potent Antitumor Activity of Interleukin-27 Cancer Res., February 1, 2004; 64(3): 1152 - 1156. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Peter, M. J. Brunda, and G. Corradin IL-12 Administration Leads to a Transient Depletion of T Cells, B Cells, and APCs and Concomitant Abrogation of the HLA-A2.1-Restricted CTL Response in Transgenic Mice J. Immunol., July 1, 2002; 169(1): 63 - 67. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ehlers, J. Benini, H.-D. Held, C. Roeck, G. Alber, and S. Uhlig {alpha}{beta} T Cell Receptor-positive Cells and Interferon-{gamma}, but not Inducible Nitric Oxide Synthase, Are Critical for Granuloma Necrosis in a Mouse Model of Mycobacteria-induced Pulmonary Immunopathology J. Exp. Med., December 17, 2001; 194(12): 1847 - 1859. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Lohr, Q. Huang, K. Hu, M. W. Dewhirst, and C.-Y. Li Systemic Vector Leakage and Transgene Expression by Intratumorally Injected Recombinant Adenovirus Vectors Clin. Cancer Res., November 1, 2001; 7(11): 3625 - 3628. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Walter, N. Kajiwara, P. Karanja, M. Castro, and M. J. Holtzman Interleukin 12 p40 Production by Barrier Epithelial Cells during Airway Inflammation J. Exp. Med., January 29, 2001; 193(3): 339 - 352. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Adris, E. Chuluyan, A. Bravo, M. Berenstein, S. Klein, M. Jasnis, C. Carbone, Y. Chernajovsky, and O. L. Podhajcer Mice Vaccination with Interleukin 12-transduced Colon Cancer Cells Potentiates Rejection of Syngeneic Non-Organ-related Tumor Cells Cancer Res., December 1, 2000; 60(23): 6696 - 6703. [Abstract] [Full Text]
|
|
|
|
|
|
G. Wunderlich, I. C. Moura, and H. A. del Portillo Genetic Immunization of BALB/c mice with a Plasmid Bearing the Gene Coding for a Hybrid Merozoite Surface Protein 1-Hepatitis B Virus Surface Protein Fusion Protects Mice against Lethal Plasmodium chabaudi chabaudi PC1 Infection Infect. Immun., October 1, 2000; 68(10): 5839 - 5845. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Nakamura, T. Otani, Y. Ijiri, R. Motoda, M. Kurimoto, and K. Orita IFN-{gamma}-Dependent and -Independent Mechanisms in Adverse Effects Caused by Concomitant Administration of IL-18 and IL-12 J. Immunol., March 15, 2000; 164(6): 3330 - 3336. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. HEREMANS, C. DILLEN, M. GROENEN, P. MATTHYS, and A. BILLIAU Role of Interferon-gamma and Nitric Oxide in Pulmonary Edema and Death Induced by Lipopolysaccharide Am. J. Respir. Crit. Care Med., January 1, 2000; 161(1): 110 - 117. [Abstract] [Full Text]
|
|
|
|
|
|
K. Dunussi-Joannopoulos, K. Runyon, J. Erickson, R. G. Schaub, R. G. Hawley, and J. P. Leonard Vaccines With Interleukin-12-Transduced Acute Myeloid Leukemia Cells Elicit Very Potent Therapeutic and Long-Lasting Protective Immunity Blood, December 15, 1999; 94(12): 4263 - 4273. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Jiang, D. M. Magee, and R. A. Cox Construction of a Single-Chain Interleukin-12-Expressing Retroviral Vector and Its Application in Cytokine Gene Therapy against Experimental Coccidioidomycosis Infect. Immun., June 1, 1999; 67(6): 2996 - 3001. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Gherardi, J. C. Ramirez, D. Rodriguez, J. R. Rodriguez, G.-I. Sano, F. Zavala, and M. Esteban IL-12 Delivery from Recombinant Vaccinia Virus Attenuates the Vector and Enhances the Cellular Immune Response Against HIV-1 Env in a Dose-Dependent Manner J. Immunol., June 1, 1999; 162(11): 6724 - 6733. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. D. Car, V. M. Eng, J. M. Lipman, and T. D. Anderson The Toxicology of Interleukin-12: A Review Toxicol Pathol, January 1, 1999; 27(1): 58 - 63. [Abstract] [PDF]
|
|
|
|
|
|
W. E. Fogler, K. Volker, M. Watanabe, J. M. Wigginton, P. Roessler, M. J. Brunda, J. R. Ortaldo, and R. H. Wiltrout Recruitment of Hepatic NK Cells by IL-12 Is Dependent on IFN-{gamma} and VCAM-1 and Is Rapidly Down-Regulated by a Mechanism Involving T Cells and Expression of Fas J. Immunol., December 1, 1998; 161(11): 6014 - 6021. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. K. Koblish, C. A. Hunter, M. Wysocka, G. Trinchieri, and W. M.F. Lee Immune Suppression by Recombinant Interleukin (rIL)-12 Involves Interferon gamma Induction of Nitric Oxide Synthase 2 (iNOS) Activity: Inhibitors of NO Generation Reveal the Extent of rIL-12 Vaccine Adjuvant Effect J. Exp. Med., November 2, 1998; 188(9): 1603 - 1610. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-H. Chow, B.-L. Chiang, Y.-L. Lee, W.-K. Chi, W.-C. Lin, Y.-T. Chen, and M.-H. Tao Development of Th1 and Th2 Populations and the Nature of Immune Responses to Hepatitis B Virus DNA Vaccines Can Be Modulated by Codelivery of Various Cytokine Genes J. Immunol., February 1, 1998; 160(3): 1320 - 1329. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Tsung, J. B. Meko, Y. L. Tsung, G. R. Peplinski, and J. A. Norton Immune Response Against Large Tumors Eradicated by Treatment with Cyclophosphamide and IL-12 J. Immunol., February 1, 1998; 160(3): 1369 - 1377. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sacco, H. Heremans, B. Echtenacher, W. A. Buurman, Z. Amraoui, M. Goldman, and P. Ghezzi Protective Effect of a Single Interleukin-12 (IL-12) Predose Against the Toxicity of Subsequent Chronic IL-12 in Mice: Role of Cytokines and Glucocorticoids Blood, December 1, 1997; 90(11): 4473 - 4479. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Cooper, J. Magram, J. Ferrante, and I. M. Orme Interleukin 12 (IL-12) Is Crucial to the Development of Protective Immunity in Mice Intravenously Infected with Mycobacterium tuberculosis J. Exp. Med., July 7, 1997; 186(1): 39 - 45. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
